Montserrat Vendrell is founding partner of Aliath Bioventures SL and a partner at Alta Life Sciences SL. She is Board Director at Peptomyc, Accure Therapeutics (Chair), Ona Therapeutics and Board observer at Inbrain Neuroelectronics and is involved in multiple startup mentorship programs.
Dr. Vendrell has over 10-years of experience in biomedical research both at Spanish institutions (CSIC) and international companies (Roche Institute of Molecular Biology), and +20 years in supporting entrepreneurs in life sciences. Montserrat was part of the founding team of Barcelona Science Park, its bioincubator and technological platforms (Deputy CEO and later, CEO). Dr.Vendrell was also founder and CEO of Biocat, Catalonia biocluster, one of the most successful in Europe. She was CEO of Biocat for 8 years. Additionally, Dr. Vendrell chaired since its birth until 2015 the Council of European Bioregions.
Dr. Vendrell holds a PhD in Biology from University of Barcelona, a master’s degree in Science Communication from Pompeu Fabra University and an Executive Degree in General Management from IESE Business School, Dr. Vendrell currently chairs the Executive Committee of the Pasqual Maragall Foundation (Alzheimer’s research) and the Board of Trustees of UPF (Pompeu Fabra University).